Related Experiment Video
Updated: May 5, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Katharina Brandl1, George Plitas, Coralia N Mihu
1Infectious Diseases Service, Department of Medicine, Immunology Program, Sloan-Kettering Institute, New York, New York, USA.
Abstract:
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Insights
Broad-spectrum antibiotics reduce RegIIIgamma, a key immune protein, allowing dangerous VRE infections. Restoring RegIIIgamma via Toll-like receptor stimulation offers a way to combat antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Antibiotic-resistant bacterial infections, like vancomycin-resistant Enterococcus (VRE), are significant healthcare challenges.
- The mechanisms by which antibiotic use promotes these infections are not fully understood.
Purpose of the Study:
- To investigate the impact of antibiotic treatment on intestinal immune defenses against antibiotic-resistant bacteria.
- To identify molecular mechanisms linking antibiotic therapy to increased susceptibility to VRE.
Main Methods:
- Antibiotic treatment of mice to assess changes in intestinal gene expression.
- Quantification of vancomycin-resistant Enterococcus (VRE) colonization in the gut.
- Stimulation of Toll-like receptor 4 (TLR4) with lipopolysaccharide (LPS) to evaluate immune response.
Main Results:
- Antibiotic therapy significantly downregulated intestinal RegIIIgamma (Reg3g) expression in mice.
- Reduced RegIIIgamma levels correlated with increased VRE colonization.
- Oral lipopolysaccharide (LPS) administration restored RegIIIgamma expression and enhanced resistance to VRE.
Conclusions:
- Antibiotic-induced suppression of RegIIIgamma compromises innate mucosal immunity against Gram-positive pathogens like VRE.
- Targeting Toll-like receptors presents a potential strategy to restore mucosal defense and combat antibiotic-resistant infections.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transduction
Development of Antibiotic Resistance
Colonisation of Pathogens
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

